Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA approved ... Help prevent kidney disease ...

The manufacturer of semaglutide, Novo Nordisk, plans to seek U.S. Food and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year, researchers said.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...

The diabetes and weight loss drug semaglutide may also reverse signs of liver disease ... would be just the second drug the FDA has approved for treatment of MASH. The first, a medication called ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy ... and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year ...